Loading this company
Lonza Group AG
LONN.SWPrices in CHF
TickerWorth ScoreD43/100
What we think
Priced above our range of CHF 167.67 to CHF 579.95.
Price
CHF 613.20CHF up +CHF 9.20 (+1.52%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:49 UTC (7 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
CHF 167.67–CHF 579.95
What the price needs: revenue growth of 20.9%/yr for 5 years (our model assumes 7.6%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price CHF 613.20Priced · Prices are delayed.
Is it a good business?
- Valuation17 out of 100
- Growth100 out of 100
- Financial health67 out of 100
- Dividend75 out of 100
- Past performance67 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
CHF 693.04 across 23 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. It operates in the Diagnostics & Research industry (Healthcare sector), headquartered in Switzerland. The company employs roughly 20,141 people.
Key stats
52-week rangeCHF 454.60–CHF 613.20
- Open
- CHF 598.80
- Day high
- CHF 613.20
- Day low
- CHF 598.80
- Previous close
- CHF 604.00
- Volume
- 155,931 · 1.19× avg
- Average volume
- 130,661
- Market cap
- CHF 42,828,484,608.00
- P/E (TTM)
- 40.64
- Earnings per share
- CHF 15.09
- Beta
- 0.81
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.